Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.

Charles S FuchsMustafa ÖzgüroğluYung-Jue BangMaria Di BartolomeoMario MandalaMin-Hee RyuLorenzo FornaroTomasz OlesinskiChristian CaglevicHyun C ChungKei MuroEric Van CutsemAnneli ElmePeter Thuss-PatienceIan ChauAtsushi OhtsuPooja BhagiaAnran WangChie-Schin ShihKohei Shitara

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)

ClinicalTrials.gov, NCT02370498.

Keyphrases

phase ii
phase iii
open label
clinical trial
papillary thyroid
double blind
placebo controlled
squamous cell
study protocol
advanced non small cell lung cancer
squamous cell carcinoma
lymph node metastasis
young adults